For the KEGG pathway analysis, lipid and atherosclerosis, the MAPK pathway, and the PI3K/Akt pathway were most vastly associated with the potential anti-UC genes of BDMC (Figure 3B), suggesting that BDMC may exert its therapeutic value for UC by modulating the above signaling pathways. The gene discussed is AKT1; the disease is atherosclerosis.